MNPR
Monopar Therapeutics
-0.53 (-0.52%)100.92USD126K成交股數677M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | 0.00 | – | – | – | – | – | 73K-19% | 82K | 112K | 128K | 90K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 4.8M | 3.5M | 2.6M | 1.7M | 1.6M | 9.9M | 984K | 1.1M | 966K | 1.3M | 1.6M | 1.7M |
| 銷售管理費用 | 1.9M | 1.7M | 1.5M | 1.5M | 1.6M | 1.2M | 591K | 658K | 757K | 749K | 733K | 872K |
| 營業利益 | −6.6M+106% | −5.2M-53% | −4.1M+160% | −3.2M+81% | −3.2M+87% | −11.1M+436% | −1.6M-32% | −1.8M-29% | −1.7M | −2.1M | −2.3M | −2.5M |
| 營業利益率 | – | – | – | – | – | – | – | -2,434.5% | -2,097.5% | -1,840.4% | -1,815.8% | -2,790.5% |
| 稅後淨利 | −5.3M+102% | −3.9M-64% | −3.4M+164% | −2.5M+43% | −2.6M+60% | −10.9M+459% | −1.3M-41% | −1.7M-30% | −1.6M | −2.0M | −2.2M | −2.4M |
| 淨利率 | – | – | – | – | – | – | – | -2,334.5% | -1,997.5% | -1,740.4% | -1,715.8% | -2,690.5% |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 52.8M | 52.5M | 128M | 39.5M | 39.7M | 45.8M | 6.0M | 6.1M | 7.8M | 5.5M | 7.2M | 5.7M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 135M | 138M | 144M | 53.9M | 55.1M | 60.3M | 6.1M | 7.2M | 8.9M | 8.6M | 10.3M | 11.8M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 4.1M | 2.6M | 2.6M | 1.7M | 1.5M | 5.3M | 1.1M | 1.1M | 1.4M | 2.0M | 2.5M | 2.9M |
| 股東權益 | 131M | 135M | 142M | 52.2M | 53.6M | 55.0M | 4.9M | 6.1M | 7.5M | 6.6M | 7.8M | 8.9M |
| 負債比 | 3.1% | 1.9% | 1.8% | 3.1% | 2.7% | 8.7% | 18.5% | 15.2% | 16.1% | 23.1% | 24.2% | 24.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −3.5M | – | – | −5.7M+242% | – | – | – | −1.7M | – | – | −2.3M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | – | −13.7M | –% | – | – |
| FY2025 | 0.00 | – | – | –% | – | – |
| FY2025 | 0.00 | – | – | –% | – | – |
| FY2025 | 0.00 | – | – | –% | – | – |
| FY2024 | 0.00 | – | −15.6M | –% | – | – |
| FY2023 | 0.00 | -100.0% | −8.4M | –% | – | – |
| FY2022 | 21K | -11.6% | −10.5M | -49,511.0% | – | – |
| FY2021 | 24K | – | −9.1M | -37,892.2% | -0.73 | – |